基金持股分佈(依持有類股)
資料日期：2024/09/13
基金持股分佈
資料日期:2024/08/31
基金持股分佈(依區域)
資料日期:2024/08/31
群益那斯達克生技基金-持股明細
資料月份：2024/08
股票名稱持股(千股)比例增減 股票名稱持股(千股)比例增減
GILEAD SCIENCES INC N/A 8.92 0.27% HARROW INC N/A 0.09 0.04%
REGENERON PHARMACEUTICALS N/A 8.77 0.72% PROTHENA CORP PLC N/A 0.09 0.00%
AMGEN INC N/A 7.91 -0.03% ANI Pharmaceuticals Inc N/A 0.09 0.00%
VERTEX PHARMACEUTICALS INC N/A 7.90 -0.05% Innoviva Inc N/A 0.09 0.00%
ASTRAZENECA PLC-SPONS ADR N/A 4.07 0.36% COLLEGIUM PHARMACEUTICAL INC N/A 0.09 0.00%
ALNYLAM PHARMACEUTICALS INC N/A 3.25 0.29% ARCUTIS BIOTHERAPEUTICS INC N/A 0.08 0.01%
BIOGEN INC N/A 2.91 -0.15% DAY ONE BIOPHARMACEUTICALS I N/A 0.08 -0.01%
MODERNA INC N/A 2.86 -1.58% VIR BIOTECHNOLOGY INC N/A 0.08 -0.02%
PROSHARES ULTRA NASD BIOTECH N/A 2.33 0.00% GRIFOLS SA-ADR N/A 0.08 0.01%
ILLUMINA INC N/A 2.04 0.12% ARS PHARMACEUTICALS INC N/A 0.08 0.02%
BIOMARIN PHARMACEUTICAL INC N/A 1.69 0.11% GENMAB A/S -SP ADR N/A 0.08 0.00%
UNITED THERAPEUTICS CORP N/A 1.63 0.22% MARAVAI LIFESCIENCES HLDGS-A N/A 0.08 -0.01%
ARGENX SE - ADR N/A 1.62 -0.01% Xencor Inc N/A 0.07 -0.01%
SANOFI-ADR N/A 1.55 0.11% AnaptysBio Inc N/A 0.07 0.01%
INCYTE CORP N/A 1.47 0.07% PetIQ Inc N/A 0.07 0.02%
VIATRIS INC N/A 1.42 0.06% OCULAR THERAPEUTIX INC N/A 0.07 0.00%
ROYALTY PHARMA PLC- CL A N/A 1.31 0.10% AURINIA PHARMACEUTICALS INC N/A 0.07 0.01%
Sarepta Therapeutics Inc N/A 1.28 0.01% PLIANT THERAPEUTICS INC N/A 0.06 0.00%
NEUROCRINE BIOSCIENCES INC N/A 1.25 -0.15% EVOLUS INC N/A 0.06 0.02%
INSMED INC N/A 1.20 0.04% RELAY THERAPEUTICS INC N/A 0.06 -0.01%
Medpace Holdings Inc N/A 1.10 -0.03% IRONWOOD PHARMACEUTICALS INC N/A 0.06 -0.02%
SUMMIT THERAPEUTICS INC N/A 0.93 0.20% BICYCLE THERAPEUTICS PLC-ADR N/A 0.06 0.00%
VAXCYTE INC N/A 0.89 0.07% PHATHOM PHARMACEUTICALS INC N/A 0.06 0.02%
Roivant Sciences Ltd N/A 0.88 0.09% ENLIVEN THERAPEUTICS INC N/A 0.06 -0.02%
BIONTECH SE-ADR N/A 0.86 0.07% ZYMEWORKS INC N/A 0.06 0.01%
ASCENDIS PHARMA A/S - ADR N/A 0.81 0.08% KINIKSA PHARMACEUTICALS INTE N/A 0.06 0.00%
HALOZYME THERAPEUTICS INC N/A 0.77 0.10% OLEMA PHARMACEUTICALS INC N/A 0.05 -0.01%
INTRA-CELLULAR THERAPIES INC N/A 0.76 -0.06% 89BIO INC N/A 0.05 0.00%
Jazz Pharmaceuticals Plc N/A 0.74 0.08% SCHOLAR ROCK HOLDING CORP N/A 0.05 0.00%
EXELIXIS INC N/A 0.74 0.07% 4D MOLECULAR THERAPEUTICS IN N/A 0.05 -0.01%
IONIS PHARMACEUTICALS INC N/A 0.71 0.02% TARSUS PHARMACEUTICALS INC N/A 0.05 0.00%
REVOLUTION MEDICINES INC N/A 0.67 -0.05% CASTLE BIOSCIENCES INC N/A 0.05 0.01%
CYTOKINETICS INC N/A 0.64 -0.03% HUMACYTE INC N/A 0.05 -0.03%
BLUEPRINT MEDICINES CORP N/A 0.56 -0.08% CENTESSA PHARMACEUTICALS-ADR N/A 0.05 0.01%
KRYSTAL BIOTECH INC N/A 0.53 -0.04% COGENT BIOSCIENCES INC N/A 0.05 0.01%
MADRIGAL PHARMACEUTICALS INC N/A 0.52 -0.08% PACIRA BIOSCIENCES INC N/A 0.05 -0.02%
BRIDGEBIO PHARMA INC N/A 0.51 0.03% ABCELLERA BIOLOGICS INC N/A 0.05 -0.02%
NUVALENT INC-A N/A 0.46 0.02% CUREVAC NV N/A 0.05 -0.01%
DYNE THERAPEUTICS INC N/A 0.44 0.03% Adaptive Biotechnologies N/A 0.05 0.01%
ULTRAGENYX PHARMACEUTICAL IN N/A 0.44 0.09% GALAPAGOS NV-SPON ADR N/A 0.04 0.01%
APELLIS PHARMACEUTICALS INC N/A 0.44 -0.01% SIGA TECHNOLOGIES INC N/A 0.04 -0.01%
ALKERMES PLC N/A 0.44 0.01% VERVE THERAPEUTICS INC N/A 0.04 0.00%
IMMUNOVANT INC N/A 0.41 0.02% ITEOS THERAPEUTICS INC N/A 0.04 0.00%
AVIDITY BIOSCIENCES INC N/A 0.41 -0.02% TRAVERE THERAPEUTICS INC N/A 0.04 -0.01%
CRINETICS PHARMACEUTICALS IN N/A 0.41 0.00% ARCTURUS THERAPEUTICS HOLDIN N/A 0.04 0.00%
AXSOME THERAPEUTICS INC N/A 0.40 0.00% AUTOLUS THERAPEUTICS PLC N/A 0.04 -0.01%
ADMA BIOLOGICS INC N/A 0.37 0.10% REPLIMUNE GROUP INC N/A 0.04 0.00%
CRISPR Therapeutics AG N/A 0.36 -0.07% Arbutus Biopharma Corp N/A 0.04 0.00%
MERUS NV N/A 0.33 -0.02% REGENXBIO INC N/A 0.04 0.00%
AMICUS THERAPEUTICS INC N/A 0.32 0.03% WAVE LIFE SCIENCES LTD N/A 0.04 0.00%
ARCELLX INC N/A 0.32 0.03% SAGE THERAPEUTICS INC N/A 0.04 -0.01%
DENALI THERAPEUTICS INC N/A 0.31 0.00% SAVARA INC N/A 0.04 0.00%
IOVANCE BIOTHERAPEUTICS INC N/A 0.31 0.08% GRAIL INC N/A 0.04 0.00%
GUARDANT HEALTH INC N/A 0.29 -0.11% MINERALYS THERAPEUTICS INC N/A 0.04 0.00%
ARROWHEAD PHARMACEUTICALS IN N/A 0.28 -0.05% ORIC PHARMACEUTICALS INC N/A 0.04 0.00%
SPRINGWORKS THERAPEUTICS INC N/A 0.28 0.03% Y-MABS THERAPEUTICS INC N/A 0.04 0.00%
IDEAYA BIOSCIENCES INC N/A 0.28 -0.02% TAYSHA GENE THERAPIES INC N/A 0.03 0.00%
IMMUNITYBIO INC N/A 0.27 -0.08% TERNS PHARMACEUTICALS INC N/A 0.03 0.00%
XENON PHARMACEUTICALS INC N/A 0.27 -0.02% ACELYRIN INC N/A 0.03 -0.01%
KYMERA THERAPEUTICS INC N/A 0.27 0.01% THIRD HARMONIC BIO INC N/A 0.03 0.00%
ACADIA PHARMACEUTICALS INC N/A 0.26 -0.04% ANAVEX LIFE SCIENCES CORP N/A 0.03 -0.01%
AGIOS PHARMACEUTICALS INC N/A 0.25 0.00% ERASCA INC N/A 0.03 0.00%
MYRIAD GENETICS INC N/A 0.25 0.00% MAXCYTE INC N/A 0.03 -0.01%
RHYTHM PHARMACEUTICALS INC N/A 0.25 -0.01% ALECTOR INC N/A 0.03 0.00%
PROTAGONIST THERAPEUTICS INC N/A 0.25 0.03% PHIBRO ANIMAL HEALTH CORP-A N/A 0.03 0.00%
PTC THERAPEUTICS INC N/A 0.24 0.01% NAUTILUS BIOTECHNOLOGY INC N/A 0.03 0.00%
VERACYTE INC N/A 0.24 0.06% Theravance Biopharma Inc N/A 0.03 -0.01%
GERON CORP N/A 0.23 0.00% PACIFIC BIOSCIENCES OF CALIF N/A 0.03 -0.01%
Twist Bioscience Corp N/A 0.22 -0.07% REVANCE THERAPEUTICS INC N/A 0.03 0.01%
JANUX THERAPEUTICS INC N/A 0.22 0.03% KALVISTA PHARMACEUTICALS INC N/A 0.03 -0.01%
FORTREA HOLDINGS INC N/A 0.21 -0.04% OMNIAB INC N/A 0.03 -0.01%
AMPHASTAR PHARMACEUTICALS IN N/A 0.21 0.02% EYEPOINT PHARMACEUTICALS INC N/A 0.03 -0.01%
Novocure Ltd N/A 0.19 -0.04% PRIME MEDICINE INC N/A 0.03 -0.01%
Intellia Therapeutics Inc N/A 0.19 -0.04% ATEA PHARMACEUTICALS INC N/A 0.03 0.00%
APOGEE THERAPEUTICS INC N/A 0.19 0.01% FULCRUM THERAPEUTICS INC N/A 0.03 0.00%
VERA THERAPEUTICS INC N/A 0.18 0.01% Allogene Therapeutics Inc N/A 0.03 0.00%
STRUCTURE THERAPEUTICS INC N/A 0.18 0.00% LEXICON PHARMACEUTICALS INC N/A 0.02 -0.01%
BEAM THERAPEUTICS INC N/A 0.18 -0.04% VOYAGER THERAPEUTICS INC N/A 0.02 -0.01%
LIGAND PHARMACEUTICALS N/A 0.18 0.00% CABALETTA BIO INC N/A 0.02 0.00%
AKERO THERAPEUTICS INC N/A 0.18 0.00% VANDA PHARMACEUTICALS INC N/A 0.02 -0.01%
SYNDAX PHARMACEUTICALS INC N/A 0.17 -0.02% Precigen Inc N/A 0.02 -0.01%
NOVAVAX INC N/A 0.17 -0.01% EDITAS MEDICINE INC N/A 0.02 -0.01%
ARVINAS INC N/A 0.17 -0.01% AMARIN CORP PLC -ADR N/A 0.02 0.00%
RECURSION PHARMACEUTICALS-A N/A 0.17 -0.02% UROGEN PHARMA LTD N/A 0.02 -0.01%
Harmony Biosciences Holdings N/A 0.16 0.01% AC IMMUNE SA N/A 0.02 0.00%
KURA ONCOLOGY INC N/A 0.16 0.00% uniQure NV N/A 0.02 0.00%
ROCKET PHARMACEUTICALS INC N/A 0.15 -0.04% BIOMEA FUSION INC N/A 0.02 0.01%
KEROS THERAPEUTICS INC N/A 0.15 -0.02% LYELL IMMUNOPHARMA INC N/A 0.02 -0.01%
NURIX THERAPEUTICS INC N/A 0.15 0.02% XERIS BIOPHARMA HOLDINGS INC N/A 0.02 0.00%
SANA BIOTECHNOLOGY INC N/A 0.14 0.00% ZENTALIS PHARMACEUTICALS INC N/A 0.02 0.00%
VERONA PHARMA PLC - ADR N/A 0.14 0.03% TOURMALINE BIO INC N/A 0.02 0.00%
SUPERNUS PHARMACEUTICALS INC N/A 0.14 0.02% ATAI LIFE SCIENCES NV N/A 0.02 0.00%
MIRUM PHARMACEUTICALS INC N/A 0.14 0.01% VENTYX BIOSCIENCES INC N/A 0.01 0.00%
IMMUNOCORE HOLDINGS PLC-ADR N/A 0.13 -0.01% 23ANDME HOLDING CO -CLASS A N/A 0.01 0.00%
AVADEL PHARMACEUTICALS N/A 0.13 -0.01% AMYLYX PHARMACEUTICALS INC N/A 0.01 0.00%
BIOCRYST PHARMACEUTICALS INC N/A 0.13 0.02% MACROGENICS INC N/A 0.01 0.00%
EDGEWISE THERAPEUTICS INC N/A 0.12 0.01% PDL BIOPHARMA INC N/A 0.01 0.00%
CULLINAN THERAPEUTICS INC N/A 0.11 0.00% ALX ONCOLOGY HOLDINGS INC N/A 0.01 -0.01%
MANNKIND CORP N/A 0.11 0.01% COHERUS BIOSCIENCES INC N/A 0.01 0.00%
DYNAVAX TECHNOLOGIES CORP N/A 0.10 0.00% OVID THERAPEUTICS INC N/A 0.01 N/A
ARDELYX INC N/A 0.10 0.01% MeiraGTx Holdings plc N/A 0.01 -0.01%
TANGO THERAPEUTICS INC N/A 0.09 0.02% CARIBOU BIOSCIENCES INC N/A 0.01 -0.01%
DISC MEDICINE INC N/A 0.09 0.02% Exscientia PLC N/A 0.01 0.00%
(1)股票型及平衡型基金自91年7月份起放寬為每月公布基金持股前五大個股名稱，及合計占基金淨資產價值之比例；每季（3、6、9、12月）公布基金投資個股內容及比例。
(2)國內募集投資國外之股票型基金，放寬為每季公布基金持股前五大個股名稱，及合計占基金淨資產價值之比例；每半年公布基金投資個股內容及比例。
註1: 基金績效計算皆有考慮配息，基金配息率不代表基金報酬率，且過去配息率不代表未來配息率。所有基金績效，均為過去績效，不代表未來之績效表現，亦不保證基金之最低投資收益。
註2: 基金淨值可能因市場因素而上下波動，基金淨值僅供參考，實際以基金公司公告之淨值為準；部份基金採雙軌報價，實際交易以基金公司所公告的買回價／賣出價為計算基礎。
註3: 上述銷售費用僅供參考，實際費率以各銷售機構為主。
註4: 上述短線交易規定資料僅供參考，實際規定應以基金公開說明書為主。
註5: 境內基金經行政院金融監督管理委員會核准在國內募集及銷售，惟不表示絕無風險。基金經理公司以往之經理績效不保證基金之最低投資收益；基金經理公司除盡善良管理人之注意義務外，不負責本基金之盈虧，亦不保證最低之收益，投資人申購前應詳閱基金公開說明書。
註6: 依金管會規定基金投資大陸證券市場之有價證券不得超過本基金資產淨值之10%，當該基金投資地區包含中國大陸及香港，基金淨值可能因為大陸地區之法令、政治或經濟環境改變而受不同程度之影響。
註7: 上述資料只供參考用途，嘉實資訊自當盡力提供正確訊息，但如有錯漏或疏忽，本公司或關係企業與其任何董事或任何受僱人，恕不負任何法律責任。